A chemist pulls a bound notebook off a shelf and lands on the page everyone trusts. The ratios are there. So is the crossed-out trial that saved six weeks. What is not there is the part the room still carries in memory: which supplier variation matters, which customer tolerance is real, and which tweak only works when one operator is watching the batch.
Inside the plant, that notebook can feel like a moat. Outside the plant, it can look unfinished. WIPO's trade-secret guidance says trade secrets can lose value when secrecy is lost or when technological and commercial change makes the information less useful. In specialty chemicals, a formulation book holds value only when another team can inherit the judgment around it, protect it, and use it without guessing.
That is why documentation has become a transfer question, not a housekeeping one. The same logic sits behind HarborWind's view of AI in specialty chemicals, the market backdrop in specialty chemicals M&A, and our work with specialty chemical businesses whose know-how should survive a handoff cleanly.
A formulation book can lose value long before a sale if the know-how inside it becomes hard to protect, hard to transfer, or hard to interpret. The formulas may still help today's team, but they become less useful to a future owner when the reasoning lives in shorthand, paper, and memory.
A founder can look at a shelf of notebooks and see years of hard-won advantage. A buyer asks a narrower question: can that advantage move into the next chapter without breaking? WIPO says companies should identify their trade secrets and understand their value so they can make informed decisions about protection, management, and licensing. That is a more grounded standard than romance about old lab books. If the caveat behind a formula lives in one chemist's shorthand, or the failed trial sits only in memory, the asset is already thinning out. In sectors where technical know-how shapes what appears in a buyer's investment criteria, that gap matters before anyone talks about price.
A buyer needs more than a formula that still works. The record has to show that the know-how is documented clearly enough to be protected, controlled, and repeated. That usually means formulas, process notes, access discipline, confidentiality controls, and evidence that the business treats technical knowledge like an operating asset.
WIPO is direct that trade secrets remain protected only while commercially valuable information stays confidential and is subject to reasonable measures. The same guidance points to practical measures that look familiar in a diligence room: limiting access, using confidentiality agreements, reviewing who truly needs to know the information, and tightening controls when employees leave. None of that makes the notebook less important. It makes the notebook legible inside a wider system. Buyers are not asking a founder-led chemical business to look like a multinational research platform. They are trying to see whether the technical edge belongs to the company, or whether it still depends on one person's habits.
A formulation book stops being an asset when the next owner inherits the ratio, but not the reasoning.
Undocumented know-how becomes riskier when skilled people are scarce because relearning is slow and turnover is expensive. In a tight labor market, one missing process judgment can become a quality problem, a training delay, or a customer issue. The weaker the record, the more the business depends on memory staying put.
Deloitte says 1.9 million manufacturing jobs could go unfilled over the next 10 years if talent challenges are not addressed. It also says 60% of surveyed HR leaders at U.S. manufacturers reported that replacing one skilled frontline worker costs between $10,000 and $40,000, while 56% said turnover has a moderate to severe impact on bottom-line finances. That is not a chemicals-only finding, but it lands hard in a plant where the person leaving rarely carries only labor capacity. They also carry edge-case knowledge. HarborWind's work with business owners starts from that reality. Preserving a legacy usually means preserving the operating memory that made the company dependable.
They fit together best as one chain. Paper can capture context. Trade-secret controls define what must stay protected. Digital systems make that knowledge searchable and easier to hand off. The strongest setup is not paper versus software. It is a documented system that keeps expert judgment intact for the next team.
The shift in research documentation is already visible. NIH says no new paper laboratory notebooks should be created after June 30, 2024, and that new research initiated after that date should be documented using approved electronic lab notebooks. NIH is not a specialty chemicals manufacturer, but it is a useful directional signal. This is also where HarborWind's technology lens matters. AI does not replace chemists or plant leaders. It captures institutional knowledge from experienced people and makes it repeatable, permanent, and scalable. It frees people for the judgment calls software cannot carry alone, which is central to HarborWind's view of founder-led industrial businesses and the operating experience on our team page.
Buy. Build. Compound.
Yes, but not by itself. WIPO says trade secrets remain protected only while commercially valuable information stays confidential and is subject to reasonable measures. A paper notebook can support that record, but buyers still look for access controls, confidentiality discipline, and a system that makes the knowledge usable beyond one person's memory.
Because a working formula is not automatically a transferable asset. If the logic behind the product lives in one chemist's shorthand or memory, the business becomes harder to diligence, protect, and hand off. Clear documentation reduces uncertainty about whether the know-how survives turnover and ownership change.
No. Electronic lab notebooks and related AI tools work best as systems for preserving and retrieving knowledge, not for replacing scientific judgment. They make prior learning easier to search and reuse. The chemist still supplies the interpretation, context, and edge-case reasoning that software cannot carry on its own.
Buyers tend to respond best when the technical story is easy to follow. That usually means legible formulation history, clear confidentiality controls, defined access to sensitive information, and a record of how key knowledge is carried forward when employees change roles or leave. The goal is clarity, not theater.